<figure>
</figure>


MC-2202


<figure>

sterling
ACCURIS
Pathology lab that cares

</figure>


Scan QR code to check
report authenticity

Passport No :


# LABORATORY TEST REPORT


<table>
<tr>
<th>Patient Information</th>
<th colspan="2">Sample Information</th>
<th>Client/Location Information</th>
</tr>
<tr>
<td rowspan="2">Name : Lyubochka Svetka Sex/Age Male / 41 Y 01-Feb-1982 Ref. Id : Ref. By :</td>
<td>Lab Id Registration on : :</td>
<td>02232160XXXX 20-Feb-2023 09:10</td>
<td>Client Name Sterling Accuris Buddy Location :</td>
</tr>
<tr>
<td>Collected at : Collected on Sample Type : :</td>
<td>non SAWPL EDTA Blood 20-Feb-2023 08:53</td>
<td>Approved on : 20-Feb-2023 11:09 Status : Final Printed On : 28-Feb-2023 10:26 Process At : 1. NRL SAWPL Gujarat Ahmedabad Paldi</td>
</tr>
</table>


# Complete Blood Count


<table>
<tr>
<th>Test</th>
<th></th>
<th>Result</th>
<th>Unit</th>
<th>Biological</th>
<th>Ref.</th>
<th>Interval</th>
</tr>
<tr>
<td>Hemoglobin</td>
<td>Colorimetric</td>
<td>14.5</td>
<td>g/dL</td>
<td>13.0 - 16.5</td>
<td></td>
<td></td>
</tr>
<tr>
<td>RBC Count</td>
<td>Electrical impedance</td>
<td>4.79</td>
<td>million/cmm</td>
<td>4.5 - 5.5</td>
<td></td>
<td></td>
</tr>
<tr>
<td>Hematocrit</td>
<td>Calculabed</td>
<td>43.3</td>
<td>%</td>
<td>40 - 49</td>
<td></td>
<td></td>
</tr>
<tr>
<td>MCV</td>
<td>Derived</td>
<td>90.3</td>
<td>fL</td>
<td>83 - 101</td>
<td></td>
<td></td>
</tr>
<tr>
<td>MCH</td>
<td>Calculated</td>
<td>30.2</td>
<td>pg</td>
<td>27.1 - 32.5</td>
<td></td>
<td></td>
</tr>
<tr>
<td>MCHC</td>
<td>Calculabed</td>
<td>33.4</td>
<td>g/dL</td>
<td>32.5 -36.7</td>
<td></td>
<td></td>
</tr>
<tr>
<td>RDW CV</td>
<td>Calculabed</td>
<td>13.60</td>
<td>%</td>
<td>11.6 - 14</td>
<td></td>
<td></td>
</tr>
<tr>
<td colspan="2">Total WBC and Differential Count</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>WBC Count</td>
<td>SF Cube cell analyst</td>
<td>H 10570</td>
<td>/cmm</td>
<td>4000 - 10000</td>
<td></td>
<td></td>
</tr>
<tr>
<th>Differential Count</th>
<th></th>
<th></th>
<th></th>
<th colspan="3">Absolute Count</th>
</tr>
<tr>
<td>Neutrophils</td>
<td>Microacaple</td>
<td>73</td>
<td>% 40 - 80</td>
<td>7716</td>
<td colspan="2">/cmm 2000 - 6700</td>
</tr>
<tr>
<td>Lymphocytes</td>
<td>Microacaple</td>
<td>19</td>
<td>% 20 - 40</td>
<td>2008</td>
<td colspan="2">/cmm 1100 - 3300</td>
</tr>
<tr>
<td>Eosinophils</td>
<td>Microacaple</td>
<td>02</td>
<td>% 1-6</td>
<td>211</td>
<td colspan="2">/cmm 00 - 400</td>
</tr>
<tr>
<td>Monocytes</td>
<td>Microacaple</td>
<td>06</td>
<td>% 2 - 10</td>
<td>634</td>
<td colspan="2">/cmm 200 - 700</td>
</tr>
<tr>
<td>Basophils</td>
<td>Microacaple</td>
<td>00</td>
<td>% 0-2</td>
<td>0</td>
<td colspan="2">/cmm 0 - 100</td>
</tr>
<tr>
<td>Platelet Count</td>
<td>Electrical Impedance</td>
<td>150000</td>
<td>/cmm</td>
<td colspan="2">150000 - 410000</td>
<td></td>
</tr>
<tr>
<td>MPV</td>
<td>Calculated</td>
<td>H 14.00</td>
<td>fL</td>
<td>7.5 - 10.3</td>
<td></td>
<td></td>
</tr>
</table>


Peripheral Smear Examination

Normochromic Normocytic

RBC Morphology
WBC Morphology
WBCs Series Shows Normal Morphology

Platelets Morphology

Platelets are adequate with normal morphology.

Parasites

Malarial parasite is not detected.

Erythrocyte Sedimentation Rate

ESR

Capillary photometry
7
mm/1hr
0 - 14

Thate

DR.TEJASWINI DHOTE
M.D. Pathology

Dr. Sanjeev Shah
MD Path

Dr.Yash Shah
MD Path

This is an Electronically Authenticated Report.

\# Referred Test

<!-- PageNumber="Page 1 of 19" -->
<!-- PageFooter="Sterling Accuris Pathology Laboratory National Reference Laboratory: 101 to 109, First Floor, Sankalp Square II, Nr. Old Sharda Mandir Cross Road, B/s. Jalaram Mandir Railway Crossing, Ellisbridge, Ahmedabad, Gujarat- 380006, Ph .: 812 813 0000 Email: customer.care@sterlingaccuris.com | Website: www.sterlingaccuris.com" -->
<!-- PageBreak -->


<figure>

sterling
ACCURIS
Pathology lab that cares

</figure>


Scan QR code to check
report authenticity

Passport No :

LABORATORY TEST REPORT


<table>
<tr>
<th>Patient Information</th>
<th colspan="2">Sample Information</th>
<th>Client/Location Information</th>
</tr>
<tr>
<td rowspan="2">Name : Lyubochka Svetka Sex/Age Male / 41 Y 01-Feb-1982 Ref. Id : Ref. By :</td>
<td>Lab Id Registration on : :</td>
<td>02232160XXXX 20-Feb-2023 09:10</td>
<td>Client Name : Sterling Accuris Buddy Location :</td>
</tr>
<tr>
<td>Collected at : Collected on Sample Type : :</td>
<td>non SAWPL EDTA Blood, 20-Feb-2023 08:53 Serum</td>
<td>Approved on : 20-Feb-2023 13:33 Status : Final Printed On : 28-Feb-2023 10:26 Process At : 1. NRL SAWPL Gujarat Ahmedabad Paldi</td>
</tr>
</table>


<table>
<tr>
<th colspan="4">Blood Group</th>
</tr>
<tr>
<th>Test</th>
<th>Result</th>
<th>Unit</th>
<th>Biological Ref. Interval</th>
</tr>
<tr>
<td>ABO Type</td>
<td>"A"</td>
<td></td>
<td></td>
</tr>
<tr>
<td>Rh (D) Type</td>
<td>Positive</td>
<td></td>
<td></td>
</tr>
</table>


Dhote

DR.TEJASWINI DHOTE
M.D. Pathology

Dr. Sanjeev Shah
MD Path

Dr.Yash Shah
MD Path

This is an Electronically Authenticated Report.

\# Referred Test

<!-- PageNumber="Page 2 of 19" -->

Sterling Accuris Pathology Laboratory
National Reference Laboratory: 101 to 109, First Floor, Sankalp Square II, Nr. Old Sharda Mandir Cross Road,
B/s. Jalaram Mandir Railway Crossing, Ellisbridge, Ahmedabad, Gujarat- 380006, Ph .: 812 813 0000
Email: customer.care@sterlingaccuris.com | Website: www.sterlingaccuris.com

<!-- PageBreak -->


<figure>
</figure>


MC-2202


<figure>

sterling
ACCURIS
Pathology lab that cares

</figure>


Scan QR code to check
report authenticity

Passport No :

LABORATORY TEST REPORT


<table>
<tr>
<th>Patient Information</th>
<th colspan="2">Sample Information</th>
<th>Client/Location Information</th>
</tr>
<tr>
<td rowspan="3">Name : Lyubochka Svetka Sex/Age : Male / 41 Y 01-Feb-1982 Ref. Id : Ref. By :</td>
<td>Co Lab Id Registration on : :</td>
<td>02232160XXXX 20-Feb-2023 09:10</td>
<td>Client Name : Sterling Accuris Buddy Location :</td>
</tr>
<tr>
<td rowspan="2">Collected at : Collected on Sample Type : :</td>
<td>non SAWPL 20-Feb-2023 08:53</td>
<td rowspan="2">Approved on : 20-Feb-2023 11:29 Status : Final Printed On : 28-Feb-2023 10:26 Process At : 1. NRL SAWPL Gujarat Ahmedabad Paldi</td>
</tr>
<tr>
<td>Serum</td>
</tr>
</table>


<table>
<tr>
<th colspan="4">Lipid Profile</th>
</tr>
<tr>
<th>Test</th>
<th>Result</th>
<th>Unit</th>
<th>Biological Ref. Interval</th>
</tr>
<tr>
<td>Cholesterol Cholesterol oxidase - Peroxidase method</td>
<td>189.0</td>
<td>mg/dL</td>
<td>Desirable : &lt; 200 Borderline High : 200-239 High : &gt;240</td>
</tr>
<tr>
<td>Triglyceride Ezymatic (Lipase/GK/GPO/POD)</td>
<td>H 168.0</td>
<td>mg/dl</td>
<td>Normal : &lt; 150 Borderline : 150-199 High : 200-499 Very High : &gt;500</td>
</tr>
<tr>
<td>HDL Cholesterol PTAMgC12</td>
<td>60.0</td>
<td>mg/dL</td>
<td>Low: &lt; 40.0 High: &gt;60.0</td>
</tr>
<tr>
<td>Direct LDL Direct measured</td>
<td>H 100.39</td>
<td>mg/dL</td>
<td>Optimal: &lt; 100 Near to above Optimal: 100-129 Borderline High: 130-159 High: 160-189 Very High: = 190</td>
</tr>
<tr>
<td>VLDL Calculated</td>
<td>33.60</td>
<td>mg/dL</td>
<td>15-35</td>
</tr>
<tr>
<td>CHOL/HDL Ratio Calculated</td>
<td>3.1</td>
<td></td>
<td>Up to 5.0</td>
</tr>
<tr>
<td>LDL/HDL Ratio Calculated</td>
<td>1.7</td>
<td></td>
<td>Up to 3.5</td>
</tr>
</table>


De

Dr. Purvish Darji
MD(Path)

Dr. Sanjeev Shah
MD Path

This is an Electronically Authenticated Report.

Dr.Yash Shah
MD Path

\# Referred Test

<!-- PageNumber="Page 3 of 19" -->

Sterling Accuris Pathology Laboratory
National Reference Laboratory: 101 to 109, First Floor, Sankalp Square II, Nr. Old Sharda Mandir Cross Road,
B/s. Jalaram Mandir Railway Crossing, Ellisbridge, Ahmedabad, Gujarat- 380006, Ph .: 812 813 0000
Email: customer.care@sterlingaccuris.com | Website: www.sterlingaccuris.com

<!-- PageBreak -->


<figure>
</figure>


MC-2202


<figure>

sterling
ACCURIS
Pathology lab that cares

</figure>


Scan QR code to check
report authenticity

Passport No :


# LABORATORY TEST REPORT


<table>
<tr>
<th>Patient Information</th>
<th colspan="2">Sample Information</th>
<th>Client/Location Information</th>
</tr>
<tr>
<td rowspan="3">Name : Lyubochka Svetka Sex/Age : Male / 41 Y 01-Feb-1982 Ref. Id : Ref. By :</td>
<td colspan="2">Lab Id : 02232160XXXX Registration on : 20-Feb-2023 09:10</td>
<td>Client Name : Sterling Accuris Buddy Location :</td>
</tr>
<tr>
<td>Collected at : Collected on :</td>
<td rowspan="2">non SAWPL 20-Feb-2023 08:53 Fluoride plasma</td>
<td rowspan="2">Approved on : 20-Feb-2023 11:45 Status : Final Printed On : 28-Feb-2023 10:26 Process At : 1. NRL SAWPL Gujarat Ahmedabad Paldi</td>
</tr>
<tr>
<td>: Sample Type</td>
</tr>
</table>


# Biochemistry


<table>
<tr>
<th>Test</th>
<th>Result</th>
<th>Unit</th>
<th>Biological Ref. Interval</th>
</tr>
<tr>
<td>Fasting Blood Sugar GOD-POD</td>
<td>H 141.0</td>
<td>mg/dL</td>
<td>74 - 106</td>
</tr>
</table>


De

Dr. Purvish Darji
MD(Path)

Dr. Sanjeev Shah
MD Path

This is an Electronically Authenticated Report.

Dr.Yash Shah
MD Path

\# Referred Test

<!-- PageNumber="Page 4 of 19" -->

Sterling Accuris Pathology Laboratory
National Reference Laboratory: 101 to 109, First Floor, Sankalp Square II, Nr. Old Sharda Mandir Cross Road,
B/s. Jalaram Mandir Railway Crossing, Ellisbridge, Ahmedabad, Gujarat- 380006, Ph .: 812 813 0000
Email: customer.care@sterlingaccuris.com | Website: www.sterlingaccuris.com

<!-- PageBreak -->


<figure>
</figure>


MC-2202


<figure>

sterling
ACCURIS
Pathology lab that cares

</figure>


Scan QR code to check
report authenticity

Passport No :


# LABORATORY TEST REPORT


<table>
<tr>
<th>Patient Information</th>
<th colspan="2">Sample Information</th>
<th>Client/Location Information</th>
</tr>
<tr>
<td rowspan="2">Name : Lyubochka Svetka Sex/Age : Male / 41 Y 01-Feb-1982 Ref. Id : Ref. By :</td>
<td>Lab Id Registration on : :</td>
<td>02232160XXXX 20-Feb-2023 09:10</td>
<td>Client Name : Sterling Accuris Buddy Location :</td>
</tr>
<tr>
<td>Collected at : Collected on Sample Type : :</td>
<td>non SAWPL EDTA Blood 20-Feb-2023 08:53</td>
<td>Approved on : 20-Feb-2023 11:33 Status : Final Printed On : 28-Feb-2023 10:26 Process At : 1. NRL SAWPL Gujarat Ahmedabad Paldi</td>
</tr>
</table>


# HbA1c (Glycosylated Hemoglobin)


<table>
<tr>
<th>Test</th>
<th>Result</th>
<th>Unit</th>
<th>Biological Ref. Interval</th>
</tr>
<tr>
<td>HbA1ç High Performance Liquid Chromatography</td>
<td>H 7.10</td>
<td>%</td>
<td>For Screening: Diabetes: &gt;6.5% Pre-Diabetes: 5.7% - 6.4% Non-Diabetes: &lt; 5.7%</td>
</tr>
<tr>
<td>Mean Blood Glucose Calculated</td>
<td>157.07</td>
<td>mg/dL</td>
<td>For Diabetic Patient: Poor Control : &gt; 7.0 % Good Control : 6.0-7.0 %</td>
</tr>
</table>


## Explanation :-

. Total haemoglobin A1 c is continuously synthesized in the red blood cell throught its 120 days life span. The concentration of HBA1c in the cell
reflects the average blood glucose concentration it encounters.

. The level of HBA1c increases proportionately in patients with uncontrolled diabetes. It reflects the average blood glucose concentration over an
extended time period and remains unaffected by short-term fluctuations in blood glucose levels.

. The measurement of HbA1c can serve as a convenient test for evaluating the adequacy of diabetic control and in preventing various diabetic
complications. Because the average half life of a red blood cell is sixty days, HbA1c has been accepted as a measurement which reflects the mean
daily blood glucose concentration, better than fasting blood glucose determination, and the degree of carbohydrate imbalance over the preceding
two months.

. It may also provide a better index of control of the diabetic patient without resorting to glucose loading procedures.

HbA1c assay Interferences:

Erroneous values might be obtained from samples with abnormally elevated quantities of other Haemoglobins as a result of
either their simultaneous elution with HbA1c (HbF) or differences in their glycation from that of HbA (HbS).

Reference: ADA Guideline 2023

Thote

DR.TEJASWINI DHOTE
M.D. Pathology

Dr. Sanjeev Shah
MD Path

Dr.Yash Shah
MD Path

This is an Electronically Authenticated Report.

\# Referred Test

<!-- PageNumber="Page 5 of 19" -->
<!-- PageFooter="Sterling Accuris Pathology Laboratory" -->
<!-- PageFooter="National Reference Laboratory: 101 to 109, First Floor, Sankalp Square II, Nr. Old Sharda Mandir Cross Road, B/s. Jalaram Mandir Railway Crossing, Ellisbridge, Ahmedabad, Gujarat- 380006, Ph .: 812 813 0000 Email: customer.care@sterlingaccuris.com | Website: www.sterlingaccuris.com" -->
<!-- PageBreak -->


<figure>
</figure>


MC-2202


<figure>

sterling
ACCURIS
Pathology lab that cares

</figure>


Scan QR code to check
report authenticity

Passport No :


# LABORATORY TEST REPORT


<table>
<tr>
<th>Patient Information</th>
<th colspan="2">Sample Information</th>
<th>Client/Location Information</th>
</tr>
<tr>
<td rowspan="2">Name : Lyubochka Svetka Sex/Age : Male / 41 Y 01-Feb-1982 Ref. Id : Ref. By :</td>
<td>Lab Id Registration on : :</td>
<td>02232160XXXX 20-Feb-2023 09:10</td>
<td>Client Name : Sterling Accuris Buddy Location :</td>
</tr>
<tr>
<td>Collec at : Collected on : Sample Type :</td>
<td>non SAWPL 20-Feb-2023 08:53 Serum</td>
<td>Approved on : 20-Feb-2023 11:38 Status : Final Printed On : 28-Feb-2023 10:26 Process At : 1. NRL SAWPL Gujarat Ahmedabad Paldi</td>
</tr>
</table>


## Thyroid Function Test

Test

Result

T3 - Trijodothyronine
Chemiluminescence

1.01

T4 - Thyroxine

7.84

TSH - Thyroid Stimulating Hormone
Chemiluminescence

0.8199


<table>
<tr>
<th>Unit</th>
<th>Biological Ref. Interval</th>
</tr>
<tr>
<td>ng/ml</td>
<td>0.58 - 1.59</td>
</tr>
<tr>
<td>mg/mL</td>
<td>4.87 - 11.72</td>
</tr>
<tr>
<td>microlU/mL</td>
<td>0.35 - 4.94</td>
</tr>
</table>


<table>
<tr>
<th>TSH</th>
<th>T3/FT3</th>
<th>T4/FT4</th>
<th>Suggested Interpretation for the Thyroid Function Tests Pattern</th>
</tr>
<tr>
<td>Within Range</td>
<td>Decreased</td>
<td>Within Range</td>
<td>· Isolated Low T3-offes seen in elderly &amp; associated Non-Thyroidal illness. In elderly the drop in T'3 level can be upto 25%</td>
</tr>
<tr>
<td>Raised</td>
<td>Within Range</td>
<td>Within Range</td>
<td>. Isolated High TSH especialy in the range of 4.7 to 15 mlU/ml is commonly associated with physiological &amp; Biological TSH Variability. . Subclinical Autoimmune Hypothyroidism Intermitod T4 therapy for hypothyroidism Recovery phase after Non-Thyroidal illness</td>
</tr>
<tr>
<td>Raised</td>
<td>Decreased</td>
<td>Decreased</td>
<td>Chronic autoimmuno Thyroidit's . Post thyroideciory, Post radiciodine . Hypothyroid phase of transient thyroiditis</td>
</tr>
<tr>
<td>Raised or Within Range</td>
<td>Raised</td>
<td>Raised or Within range</td>
<td>- Interfering antibodies to thyroid hormones (anti-TPO antibodies) . intermittent T4 therapy or T4 overdose · Drug interference-Amiodarone, Heparin, Beta blockers, steroids, anti-epileptics</td>
</tr>
<tr>
<td>Decreased</td>
<td>Raised or within Range</td>
<td>Raised or within Range</td>
<td>. Isolated Low TSH- especially in the range of 0.1 to 0.4 offen seen in elderly &amp; associated with Non-Thyroidal illness . Subclinical Hypernyoidsm . Thyroxine ingestion</td>
</tr>
<tr>
<td>Decreased</td>
<td>Decreased</td>
<td>Decreased</td>
<td>. Central Hypothyroidism - Non-Thyroidal illness Recent treatment for Hyperthyroidism (TSH remains suppressed)</td>
</tr>
<tr>
<td>Decreased</td>
<td>Raised</td>
<td>Raised</td>
<td>Primary Hyperthyroidism (Graves disease), Multinodular goitre Toxic nodule · Transient thyroiditis:Postpartum, Silent (lymphocytic), Postvital (granulomatous, subacuto, DoQuervain'a) Gestational thyrotoxicosis with hyporomosis gravidarum</td>
</tr>
<tr>
<td>Decreased or within range</td>
<td>Raised</td>
<td>Within Range</td>
<td>TS toxicagis Non-Thyroidal illness</td>
</tr>
</table>


De

Dr. Purvish Darji
MD(Path)

Dr. Sanjeev Shah
MD Path

This is an Electronically Authenticated Report.

Dr.Yash Shah
MD Path

\# Referred Test

<!-- PageNumber="Page 6 of 19" -->

Sterling Accuris Pathology Laboratory
National Reference Laboratory: 101 to 109, First Floor, Sankalp Square II, Nr. Old Sharda Mandir Cross Road,
B/s. Jalaram Mandir Railway Crossing, Ellisbridge, Ahmedabad, Gujarat- 380006, Ph .: 812 813 0000
Email: customer.care@sterlingaccuris.com | Website: www.sterlingaccuris.com

<!-- PageBreak -->


<figure>
</figure>


MC-2202


<figure>

sterling
ACCURIS
Pathology lab that cares

</figure>


Scan QR code to check
report authenticity

Passport No :


## LABORATORY TEST REPORT


<table>
<tr>
<th></th>
<th>Patient Information</th>
<th>Sample Information</th>
<th>Client/Location Information</th>
</tr>
<tr>
<td>Name Sex/Age</td>
<td rowspan="2">: Male / 41 Y : Lyubochka Svetka 01-Feb-1982 : :</td>
<td>Lab Id : 02232160XXXX Registration on 20-Feb-2023 09:10</td>
<td>Client Name : Sterling Accuris Buddy Location :</td>
</tr>
<tr>
<td>Ref. By Ref. Id</td>
<td>Collected at : non SAWPL Collected on : 20-Feb-2023 08:53 Sample Type : Urine</td>
<td>Approved on : 20-Feb-2023 12:40 Status : Final Printed On : 28-Feb-2023 10:26 Process At : 1. NRL SAWPL Gujarat Ahmedabad Paldi</td>
</tr>
</table>


# Biochemistry


<table>
<tr>
<th>Test</th>
<th>Result</th>
<th>Unit</th>
<th>Biological Ref. Interval</th>
</tr>
<tr>
<td>Microalbumin (per urine volume) Immunoturbidimetric</td>
<td>10.50</td>
<td>mg/L</td>
<td>&lt; 16.7</td>
</tr>
</table>


In random urine specimens, normal urinary albumin excretion is below 17 mg/g creatinine for males and below 25 mg/g creatinine for females.(3)
Microalbuminuria is defined as an albumin:creatinine ratio of 17 to 299 for males and 25 to 299 for females.

A ratio of albumin:creatinine of 300 or higher is indicative of overt proteinuria.

Due to biologic variability, positive results should be confirmed by a second, first-morning random or 24-hour timed urine specimen. If there is
discrepancy, a third specimen is recommended. When 2 out of 3 results are in the microalbuminuria range, this is evidence for incipient nephropathy
and warrants increased efforts at glucose control, blood pressure control, and institution of therapy with an angiotensin-converting-enzyme (ACE)
inhibitor (if the patient can tolerate it).


## Reference :

1\.
Bennett PH, Haffner S, Kasiske BL, et al: Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations
to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Melitus of the National
Kidney Foundation. Am J Kidney Dis 1995:25:107-112

2\.
Krolewski AS, Laffel LM, Krolewski M, et al: Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent
diabetes mellitus. N Engl J Med 1995;332:1251-1255

3\.
Zelmanovitz T, Gross JL, Oliveira JR, et al: The receiver operating characteristics curve in the evaluation of a random urine specimen as a
screening test for diabetic nephropathy. Diabetes Care 1997;20:516-519

De

Dr. Purvish Darji
MD(Path)

Dr. Sanjeev Shah
MD Path

This is an Electronically Authenticated Report.

Dr.Yash Shah
MD Path

\# Referred Test

<!-- PageNumber="Page 7 of 19" -->
<!-- PageFooter="Sterling Accuris Pathology Laboratory National Reference Laboratory: 101 to 109, First Floor, Sankalp Square II, Nr. Old Sharda Mandir Cross Road, B/s. Jalaram Mandir Railway Crossing, Ellisbridge, Ahmedabad, Gujarat- 380006, Ph .: 812 813 0000 Email: customer.care@sterlingaccuris.com | Website: www.sterlingaccuris.com" -->
<!-- PageBreak -->


<figure>
</figure>


MC-2202

Scan QR code to check
report authenticity


<figure>

sterling
ACCURIS
Pathology lab that cares

</figure>


Passport No :

LABORATORY TEST REPORT


<table>
<tr>
<th>Patient Information</th>
<th colspan="2">Sample Information</th>
<th>Client/Location Information</th>
</tr>
<tr>
<td rowspan="3">Name : Lyubochka Svetka Sex/Age Male / 41 Y 01-Feb-1982 Ref. Id : Ref. By :</td>
<td>Lab Id Registration on : :</td>
<td>02232160XXXX 20-Feb-2023 09:10</td>
<td>Client Name : Sterling Accuris Buddy Location :</td>
</tr>
<tr>
<td rowspan="2">Collected at : Collected on Sample Type : :</td>
<td>non SAWPL 20-Feb-2023 08:53</td>
<td rowspan="2">Approved on : 20-Feb-2023 11:41 Status : Final Printed On : 28-Feb-2023 10:26 Process At : 1. NRL SAWPL Gujarat Ahmedabad Paldi</td>
</tr>
<tr>
<td>Serum</td>
</tr>
</table>


<table>
<tr>
<th></th>
<th colspan="3">Protein</th>
</tr>
<tr>
<th>Test</th>
<th>Result</th>
<th>Unit</th>
<th>Biological Ref. Interval</th>
</tr>
<tr>
<td>Total Protein Copper tartrate to colour complex</td>
<td>7.00</td>
<td>g/dL</td>
<td>6.3-8.2</td>
</tr>
<tr>
<td>Albumin Bromocresol Green Method</td>
<td>4.20</td>
<td>g/dL</td>
<td>3.5-5.0</td>
</tr>
<tr>
<td>Globulin Calculated</td>
<td>2.80</td>
<td>g/dL</td>
<td>2.3 -3.5</td>
</tr>
<tr>
<td>A/G Ratio Calculated</td>
<td>1.50</td>
<td></td>
<td>1.3 -1.7</td>
</tr>
<tr>
<td></td>
<td>Bilirubin</td>
<td></td>
<td></td>
</tr>
<tr>
<td>Total Bilirubin Azobilirubin chromophores</td>
<td>0.70</td>
<td>mg/dL</td>
<td>0.2- 1.3</td>
</tr>
<tr>
<td>Conjugated Bilirubin Cationic Mordant Binding</td>
<td>0.30</td>
<td>mg/dL</td>
<td>0.0 - 0.3</td>
</tr>
<tr>
<td>Unconjugated Bilirubin Cationic Mordant Binding</td>
<td>0.20</td>
<td>mg/dl</td>
<td>0.0 - 1.1</td>
</tr>
<tr>
<td>Delta Bilirubin Calculated</td>
<td>0.20</td>
<td>mg/dL</td>
<td>0.0 - 0.2</td>
</tr>
</table>


De

Dr. Purvish Darji
MD(Path)

Dr. Sanjeev Shah
MD Path

This is an Electronically Authenticated Report.

Dr.Yash Shah
MD Path

\# Referred Test

<!-- PageNumber="Page 8 of 19" -->

Sterling Accuris Pathology Laboratory
National Reference Laboratory: 101 to 109, First Floor, Sankalp Square II, Nr. Old Sharda Mandir Cross Road,
B/s. Jalaram Mandir Railway Crossing, Ellisbridge, Ahmedabad, Gujarat- 380006, Ph .: 812 813 0000
Email: customer.care@sterlingaccuris.com | Website: www.sterlingaccuris.com

<!-- PageBreak -->


<figure>
</figure>


MC-2202

Scan QR code to check
report authenticity


<figure>

sterling
ACCURIS
Pathology lab that cares

</figure>


Passport No :

LABORATORY TEST REPORT


<table>
<tr>
<th>Patient Information</th>
<th colspan="2">Sample Information</th>
<th>Client/Location Information</th>
</tr>
<tr>
<td rowspan="3">Name : Lyubochka Svetka Sex/Age Male / 41 Y 01-Feb-1982 Ref. Id : Ref. By :</td>
<td colspan="2">Lab Id : 02232160XXXX Registration on : 20-Feb-2023 09:10</td>
<td>Client Name : Sterling Accuris Buddy Location :</td>
</tr>
<tr>
<td>Collected at : Collected on :</td>
<td rowspan="2">non SAWPL 20-Feb-2023 08:53 Serum</td>
<td rowspan="2">Approved on : 20-Feb-2023 11:29 Status : Final Printed On : 28-Feb-2023 10:26 Process At : 1. NRL SAWPL Gujarat Ahmedabad Paldi</td>
</tr>
<tr>
<td>: Sample Type</td>
</tr>
</table>


<table>
<tr>
<th colspan="4">Iron Studies</th>
</tr>
<tr>
<th>Test</th>
<th>Result</th>
<th>Unit</th>
<th>Biological Ref. Interval</th>
</tr>
<tr>
<td>Iron Pyndyl azo Dye</td>
<td>103.00</td>
<td>micro g/dl</td>
<td>49 - 181</td>
</tr>
<tr>
<td>Total Iron Binding Capacity (TIBC)</td>
<td>352.00</td>
<td></td>
<td>261 - 462</td>
</tr>
<tr>
<td>Transferrin Saturation Calculated</td>
<td>29.26</td>
<td>%</td>
<td>Children : &gt;16 Adult : 20 - 50</td>
</tr>
</table>


Pe

Dr. Purvish Darji
MD(Path)

Dr. Sanjeev Shah
MD Path

Dr.Yash Shah
MD Path

This is an Electronically Authenticated Report.

\# Referred Test

<!-- PageNumber="Page 9 of 19" -->
<!-- PageFooter="Sterling Accuris Pathology Laboratory National Reference Laboratory: 101 to 109, First Floor, Sankalp Square II, Nr. Old Sharda Mandir Cross Road, B/s. Jalaram Mandir Railway Crossing, Ellisbridge, Ahmedabad, Gujarat- 380006, Ph .: 812 813 0000 Email: customer.care@sterlingaccuris.com | Website: www.sterlingaccuris.com" -->
<!-- PageBreak -->


<figure>
</figure>


MC-2202


<figure>

sterling
ACCURIS
Pathology lab that cares

</figure>


Scan QR code to check
report authenticity

Passport No :


# LABORATORY TEST REPORT


<table>
<tr>
<th>Patient Information</th>
<th colspan="2">Sample Information</th>
<th>Client/Location Information</th>
</tr>
<tr>
<td rowspan="3">Name : Lyubochka Svetka Sex/Age : Male / 41 Y 01-Feb-1982 Ref. Id : Ref. By :</td>
<td>Lab Id Registration on : :</td>
<td>20-Feb-2023 09:10 02232160XXXX</td>
<td>Client Name : Sterling Accuris Buddy Location :</td>
</tr>
<tr>
<td rowspan="2">Collected at : Collected on Sample Type : :</td>
<td>non SAWPL 20-Feb-2023 08:53</td>
<td rowspan="2">Approved on : 20-Feb-2023 11:38 Status : Final Printed On : 28-Feb-2023 10:26 Process At : 1. NRL SAWPL Gujarat Ahmedabad Paldi</td>
</tr>
<tr>
<td>Serum</td>
</tr>
</table>


# Immunoassay


<table>
<tr>
<th>Test</th>
<th>Result</th>
<th>Unit</th>
<th>Biological Ref. Interval</th>
</tr>
<tr>
<td>Homocysteine, Serum Chemiluminescence</td>
<td>H 23.86</td>
<td>micromol/L</td>
<td>6.0 - 14.8</td>
</tr>
</table>


Summary and Uses:

. Total Hcy is a thiol-containing amino acid, produced by the intracellular demethylation of methionine to
cysteine.

· Elevated levels of t Hcy may be used to exclude or confirm deficiencies of vitamin B12 or folate.

. It is recommended to test in patients using medications that interfere with folate status (methotrexate,
antiepileptics), vegetarians without B12 supplementations, unexplained anemia, peripheral neuropathy or
myleopathy, recurrent spontaneous abortions or infertility.

· Testing also recommended for patients 40 years of age with coronary artery disease to exclude
homocystinuria.

· Elevations in tHcy levels have also been used as an independent risk factor of coronary or cerebral
vascular disease. Treatment of moderate hyperhomocystinemia with folic acid supplementation for primary
and secondary cardiovascular protection has met with inconsistent results and at present cannot be
routinely recommended.


## Limitations:

. The plasma must be seprated immediately on collection to avoid continuous synthesis of Hcy by red cells.

· Samples must be immediately stored on ice and serum centrifuged immediately before a complete clot is
formed.

· Certain drugs, such as anticonvulsants, methotrexate, or nitrous oxide, may interfere with the assay.

· Cigarette smoking and coffee consumption increase tHcy levels.

· Intraindividual variability is approximately 8%; it can be as much as 25% in patients with
hyperhomocystinemia.

· Generally, a single measurement of tHcy is considered adequate.

De

Dr. Purvish Darji
MD(Path)

Dr. Sanjeev Shah
MD Path

This is an Electronically Authenticated Report.

Dr.Yash Shah
MD Path

\# Referred Test

<!-- PageNumber="Page 10 of 19" -->
<!-- PageFooter="Sterling Accuris Pathology Laboratory" -->
<!-- PageFooter="National Reference Laboratory: 101 to 109, First Floor, Sankalp Square II, Nr. Old Sharda Mandir Cross Road, B/s. Jalaram Mandir Railway Crossing, Ellisbridge, Ahmedabad, Gujarat- 380006, Ph .: 812 813 0000 Email: customer.care@sterlingaccuris.com | Website: www.sterlingaccuris.com" -->
<!-- PageBreak -->


<figure>
</figure>


MC-2202


<figure>

sterling
ACCURIS
Pathology lab that cares

</figure>


Scan QR code to check
report authenticity

Passport No :


# LABORATORY TEST REPORT


<table>
<tr>
<th>Patient Information</th>
<th colspan="2">Sample Information</th>
<th>Client/Location Information</th>
</tr>
<tr>
<td rowspan="3">Name : Lyubochka Svetka Sex/Age : Male / 41 Y 01-Feb-1982 Ref. Id : Ref. By :</td>
<td>Lab Id Registration on : :</td>
<td>02232160XXXX 20-Feb-2023 09:10</td>
<td>Client Name : Sterling Accuris Buddy Location :</td>
</tr>
<tr>
<td rowspan="2">Collected at : Collected on Sample Type : :</td>
<td>non SAWPL 20-Feb-2023 08:53</td>
<td rowspan="2">Approved on : 20-Feb-2023 11:10 Status : Final Printed On : 28-Feb-2023 10:26 Process At : 1. NRL SAWPL Gujarat Ahmedabad Paldi</td>
</tr>
<tr>
<td>Serum</td>
</tr>
</table>


## Biochemistry


<table>
<tr>
<th>Test</th>
<th>Result</th>
<th>Unit</th>
<th>Biological Ref. Interval</th>
</tr>
<tr>
<td>Creatinine, Serum Creatinine Amidohydrolase</td>
<td>0.83</td>
<td>mg/dL</td>
<td>0.66 - 1.25</td>
</tr>
<tr>
<td>Urea Urease, Colorimetric</td>
<td>L 18.0</td>
<td>mg/dl</td>
<td>19.3 - 43.0</td>
</tr>
<tr>
<td>Blood Urea Nitrogen Calculated</td>
<td>L 8.41</td>
<td>mg/dL</td>
<td>9.0 - 20.0</td>
</tr>
<tr>
<td>Uric Acid Uncase</td>
<td>4.90</td>
<td>mg/dL</td>
<td>3.5 - 8.5</td>
</tr>
<tr>
<td>Calcium Arsenazo III</td>
<td>9.10</td>
<td>mg/dL</td>
<td>8.4 - 10.2</td>
</tr>
<tr>
<td>SGPT ŮV with PSP, IFCC</td>
<td>48.0</td>
<td>U/L</td>
<td>0- 50</td>
</tr>
<tr>
<td>SGOT UV with PSP</td>
<td>27.0</td>
<td>U/L</td>
<td>17-59</td>
</tr>
<tr>
<td></td>
<td>Electrolytes</td>
<td></td>
<td></td>
</tr>
<tr>
<td>Sodium (Na+) Direct- ISE</td>
<td>143.00</td>
<td>mmol/L</td>
<td>136 - 145</td>
</tr>
<tr>
<td>Potassjum (K+) Direct- ISE</td>
<td>4.90</td>
<td>mmol/L</td>
<td>3.5 -5.1</td>
</tr>
<tr>
<td>Chloride (CI-) Direct- ISE</td>
<td>105.0</td>
<td>mmol/L</td>
<td>98 - 107</td>
</tr>
</table>


De

Dr. Purvish Darji
MD(Path)

Dr. Sanjeev Shah
MD Path

This is an Electronically Authenticated Report.

Dr.Yash Shah
MD Path

\# Referred Test

<!-- PageNumber="Page 11 of 19" -->

Sterling Accuris Pathology Laboratory
National Reference Laboratory: 101 to 109, First Floor, Sankalp Square II, Nr. Old Shards Mandir Cross Road,
B/s. Jalaram Mandir Railway Crossing, Ellisbridge, Ahmedabad, Gujarat- 380006, Ph .: 812 813 0000
Email: customer.care@sterlingaccuris.com | Website: www.sterlingaccuris.com

<!-- PageBreak -->


<figure>
</figure>


MC-2202


<figure>

sterling
ACCURIS
Pathology lab that cares

</figure>


Scan QR code to check
report authenticity

Passport No :


## LABORATORY TEST REPORT


<table>
<tr>
<th>Patient Information</th>
<th colspan="2">Sample Information</th>
<th>Client/Location Information</th>
</tr>
<tr>
<td rowspan="3">Name : Lyubochka Svetka Sex/Age : Male / 41 Y 01-Feb-1982 Ref. Id : Ref. By :</td>
<td>Lab Id Registration on : :</td>
<td>20-Feb-2023 09:10 02232160XXXX</td>
<td>Client Name : Sterling Accuris Buddy Location :</td>
</tr>
<tr>
<td rowspan="2">Collected at : Collected on Sample Type : :</td>
<td>non SAWPL 20-Feb-2023 08:53</td>
<td rowspan="2">Approved on : 20-Feb-2023 12:33 Status : Final Printed On : 28-Feb-2023 10:26 Process At : 1. NRL SAWPL Gujarat Ahmedabad Paldi</td>
</tr>
<tr>
<td>Serum</td>
</tr>
</table>


## Immunoassay

Test

Result

Unit

Biological Ref. Interval

25(OH) Vitamin D
CLIA

8.98

ng/ml

Deficiency : < 10
Insufficiency : 10 - 30
Sufficiency : 30 - 100

Toxicity : >100

Vitamin D is a fat soluble vitamin and exists in two main forms as cholecalciferol(vitamin D3) which is synthesized in skin from 7-dehydrocholesterol in
response to sunlight exposure & Ergocalciferol(vitamin D2) present mainly in dietary sources.Both cholecalciferol & Ergocalciferol are converted to
25(OH)vitamin D in liver.

Interpretation;

Increased In

· Vitamin D intoxication

· Excessive exposure to sunlight

Decreased In

· Malabsorption

· Steatorrhea

. Dietary osteomalacia, anticonvulsant osteomalacia

. Biliary and portal cirrhosis

. Thyrotoxicosis

· Pancreatic insufficiency

· Celiac disease

· Rickets

· Alzheimer disease

Limitations:

More recently, it has become clear that receptors for vitamin D are present in a wide variety of cells and that this hormone has biologic effects extending
beyond the control of mineral metabolism. Vitamin D deficiency is not clear. Levels needed to prevent rickets and osteomalacia (15 ng/ml) are lower
than those that dramatically suppress parathyroid hormone levels (20-30 ng/ml). In turn, those levels are lower than levels needed to optimize intestinal
calcium absorption (34 ng/ml). Neuromuscular peak performance is associated with levels approximately 38 ng/ml. A recent study states that
increasing mean baseline levels from 29 to 38 ng/ml was associated with a 50% lower risk for colon cancer and levels of 52 ng/ml with a 50% reduction
in the incidence of breast cancer. It is recommended to have clinical correlation with serum 25(OH)vitamin D, serum calcium, serum PTH & serum
alkaline phosphatase.

Dhote

DR.TEJASWINI DHOTE
M.D. Pathology

Dr. Sanjeev Shah
MD Path

This is an Electronically Authenticated Report.

Dr.Yash Shah
MD Path

\# Referred Test

<!-- PageNumber="Page 12 of 19" -->
<!-- PageFooter="Sterling Accuris Pathology Laboratory National Reference Laboratory: 101 to 109, First Floor, Sankalp Square II, Nr. Old Sharda Mandir Cross Road, B/s. Jalaram Mandir Railway Crossing, Ellisbridge, Ahmedabad, Gujarat- 380006, Ph .: 812 813 0000 Email: customer.care@sterlingaccuris.com | Website: www.sterlingaccuris.com" -->
<!-- PageBreak -->


<figure>
</figure>


MC-2202


<figure>

sterling
ACCURIS
Pathology lab that cares

</figure>


Scan QR code to check
report authenticity

Passport No :


## LABORATORY TEST REPORT


<table>
<tr>
<th>Patient Information</th>
<th colspan="2">Sample Information</th>
<th>Client/Location Information</th>
</tr>
<tr>
<td rowspan="3">Name : Lyubochka Svetka Sex/Age : Male / 41 Y 01-Feb-1982 Ref. Id : Ref. By :</td>
<td>Lab Id Registration on : :</td>
<td>20-Feb-2023 09:10 02232160XXXX</td>
<td>Client Name : Sterling Accuris Buddy Location :</td>
</tr>
<tr>
<td rowspan="2">Collected at : Collected on Sample Type : :</td>
<td>non SAWPL 20-Feb-2023 08:53</td>
<td rowspan="2">Approved on : 20-Feb-2023 12:04 Status : Final Printed On : 28-Feb-2023 10:26 Process At : 1. NRL SAWPL Gujarat Ahmedabad Paldi</td>
</tr>
<tr>
<td>Serum</td>
</tr>
</table>


## Immunoassay


<table>
<tr>
<th>Test</th>
<th>Result</th>
<th>Unit</th>
<th>Biological Ref. Interval</th>
</tr>
<tr>
<td>Vitamin B12 CLIA</td>
<td>L &lt; 148</td>
<td>pg/mL</td>
<td>187 - 833</td>
</tr>
</table>


Vitamin B12 is essential in DNA synthesis, hematopoiesis, and CNS integrity.


### Interpretation:

. Increased In : Chronic granulocytic leukemia, COPD and Chronic renal failure, Leukocytosis, Liver cell damage (hepatitis, cirrhosis), Obesity and
Severe CHF, Polycythemia vera , Protein malnutrition.

. Decreased In : Abnormalities of cobalamin transport or metabolism , Bacterial overgrowth , Crohn disease , Dietary deficiency (e.g. in vegetarians)
, Diphyllobothrium (fish tapeworm) infestation , Gastric or small intestine surgery , Hypochlorhydria , Inflammatory bowel diseas , Intestinal
malabsorption and Intrinsic factor deficiency


### Limitations:

. Drugs such as chloral hydrate increase vitamin B12 levels. On the other hand , alcohol, aminosalicylic acid, anticonvulsants, ascorbic acid,
cholestyramine, cimetidine, colchicines, metformin, neomycin, oral contraceptives, ranitidine, and triamterene decrease vitamin B12 levels.

. The evaluation of macrocytic anemia requires measurements of both vitamin B12 and folate levels; ideally they should be measured
simultaneously.

. Specimen collection soon after blood transfusion can falsely increase vitamin B12 levels.

· Patients taking vitamin B12 supplementation may have misleading results.

. A normal serum concentration of B12 does not rule out tissue deficiency of vitamin B12. The most sensitive test for B12 deficiency at the
cellular level is the assay for MMA. If clinical symptoms suggest deficiency, measurement of MMA and homocysteine should be considered,
even if serum B12 concentrations are normal.

Dhote

DR.TEJASWINI DHOTE
M.D. Pathology

Dr. Sanjeev Shah
MD Path

This is an Electronically Authenticated Report.

Dr.Yash Shah
MD Path

\# Referred Test

<!-- PageNumber="Page 13 of 19" -->
<!-- PageFooter="Sterling Accuris Pathology Laboratory National Reference Laboratory: 101 to 109, First Floor, Sankalp Square II, Nr. Old Sharda Mandir Cross Road, B/s. Jalaram Mandir Railway Crossing, Ellisbridge, Ahmedabad, Gujarat- 380006, Ph .: 812 813 0000 Email: customer.care@sterlingaccuris.com | Website: www.sterlingaccuris.com" -->
<!-- PageBreak -->


<figure>
</figure>


MC-2202


<figure>

sterling
ACCURIS
Pathology lab that cares

</figure>


Scan QR code to check
report authenticity

Passport No :


## LABORATORY TEST REPORT


<table>
<tr>
<th>Patient Information</th>
<th colspan="2">Sample Information</th>
<th>Client/Location Information</th>
</tr>
<tr>
<td rowspan="3">Name : Lyubochka Svetka Sex/Age : Male / 41 Y 01-Feb-1982 Ref. Id : Ref. By :</td>
<td>Lab Id Registration on : :</td>
<td>20-Feb-2023 09:10 02232160XXXX</td>
<td>Client Name : Sterling Accuris Buddy Location :</td>
</tr>
<tr>
<td rowspan="2">Collected at : Collected on Sample Type : :</td>
<td>non SAWPL 20-Feb-2023 08:53</td>
<td rowspan="2">Approved on : 20-Feb-2023 11:38 Status : Final Printed On : 28-Feb-2023 10:26 Process At : 1. NRL SAWPL Gujarat Ahmedabad Paldi</td>
</tr>
<tr>
<td>Serum</td>
</tr>
</table>


## Immunoassay

Test

Result

PSA-Prostate Specific Antigen, Total

0.573

Unit
ng/ml

Biological Ref. Interval

0-4

PSA is a glycoprotein that is expresses by both normal and neoplastic prostate tissue and is prostate tissue specific and not prostate cancer specific.
PSA is constantly expressed in nearly all prastate cancers, although its level of expression on a percell basis is lower than in normal prostate epithelium.
The absolute value of serum PSA is useful for determining the extent of prostate cancer and assessing the response to prostate cancer treatment; its
use as a screening method to detect prostate cancer is also common.

Interpretation
Increased in

· Prostate disease (Cancer, Prostatitis, Benign prostatic hyperplasia, Acute urinary retention)

. Manipulations ( Cystoscopy, Needle biopsy, Radiation therapy, Indwelling catheter, Prostatic massage)

· Transurethral resection

· Prostatic ischemia

Decreased in

· Castration

· Prostatectomy

. Radiation therapy

. Ejaculation withi 24 - 48 hours

. 5-alpha-reductase inhibitor reduces PSA by 50% after 6 months in men without cancer

Limitations

. PSA has been recommended by the American Cancer Society for use in conjunction with a DRE for early detection of prostate cancer starting
at the age of 50 years for men with at least 10 year life expectancy

· PSA levels that are measured repeatedly over time may vary because of biologic variability where the true PSA level in a given man is different
on different measurements.

. A change in PSA of >30% in man with a PSA initially below 2.0 ng/ml was likely to indicate a true change beyond normal random variation.

De

Dr. Purvish Darji
MD(Path)

Dr. Sanjeev Shah
MD Path

This is an Electronically Authenticated Report.

Dr.Yash Shah
MD Path

\# Referred Test

<!-- PageNumber="Page 14 of 19" -->
<!-- PageFooter="Sterling Accuris Pathology Laboratory" -->
<!-- PageFooter="National Reference Laboratory: 101 to 109, First Floor, Sankalp Square II, Nr. Old Sharda Mandir Cross Road, B/s. Jalaram Mandir Railway Crossing, Ellisbridge, Ahmedabad, Gujarat- 380006, Ph .: 812 813 0000 Email: customer.care@sterlingaccuris.com | Website: www.sterlingaccuris.com" -->
<!-- PageBreak -->


<figure>

sterling
ACCURIS
Pathology lab that cares

</figure>


Scan QR code to check
report authenticity

Passport No :


## LABORATORY TEST REPORT


<table>
<tr>
<th>Patient Information</th>
<th colspan="2">Sample Information</th>
<th>Client/Location Information</th>
</tr>
<tr>
<td rowspan="3">Name : Lyubochka Svetka Sex/Age : Male / 41 Y 01-Feb-1982 Ref. Id : Ref. By :</td>
<td>Lab Id Registration on : :</td>
<td>02232160XXXX 20-Feb-2023 09:10</td>
<td>Client Name : Sterling Accuris Buddy Location :</td>
</tr>
<tr>
<td rowspan="2">Collected at : Collected on Sample Type : :</td>
<td>non SAWPL 20-Feb-2023 08:53</td>
<td rowspan="2">Approved on : 20-Feb-2023 12:06 Status : Final Printed On : 28-Feb-2023 10:26 Process At : 1. NRL SAWPL Gujarat Ahmedabad Paldi</td>
</tr>
<tr>
<td>Serum</td>
</tr>
</table>


## Immunoassay


<table>
<tr>
<th>Test</th>
<th>Result</th>
<th>Unit</th>
<th>Biological Ref. Interval</th>
</tr>
<tr>
<td>IgE CCIA</td>
<td>H 492.30</td>
<td>IU/mL</td>
<td>0 - 87</td>
</tr>
</table>


IgE mediates allergic and hypersensitivity reactions. There is a significant overlap in total IgE between allergic and nonallergic individuals.
Interpretation:

\- Increased In

· Atopic diseases

· Exogenous asthama in approximately 60% of patients

. Hay fever in approximately 30% of patients and Atopic eczema

. Influenced by type of allergen, duration of stimulation. Presence of symptoms, and hyposensitization treatment

. Parasitic diseases (e.g. ascariasis, visceral larva migrans, hookworm disease, schistosomiasis, Echinococcus infestation)

· Monoclonal IgE myeloma

\- Decreased In

· Hereditary deficiencies

· Acquired immunodeficiency

· Ataxia-telangiectasis

· Non-IgE myeloma


### Limitations:

. A normal level of IgE in serum does not eliminate the possibility of allergic disease.

· Serum total IgE levels for the majority of individuals with IgE-mediated disease can be expected to be elevated compared to the reference
range for healthy adults. However, not all allergic patients exhibit elevated serum total IgE levels.

. Since not all atopic reactions are IgE-mediated, a total IgE result in the reference range should always be interpreted in light of other clinical
observations.

· Heterophilic antibodies in human serum can react with the immunoglobulins included in the assay components causing interference with in vitro
immunoassays.

De

Dr. Purvish Darji
MD(Path)

Dr. Sanjeev Shah
MD Path

Dr.Yash Shah
MD Path

This is an Electronically Authenticated Report.

\# Referred Test

<!-- PageNumber="Page 15 of 19" -->
<!-- PageFooter="Sterling Accuris Pathology Laboratory" -->
<!-- PageFooter="National Reference Laboratory: 101 to 109, First Floor, Sankalp Square II, Nr. Old Sharda Mandir Cross Road, B/s. Jalaram Mandir Railway Crossing, Ellisbridge, Ahmedabad, Gujarat- 380006, Ph .: 812 813 0000 Email: customer.care@sterlingaccuris.com | Website: www.sterlingaccuris.com" -->
<!-- PageBreak -->


<figure>
</figure>


MC-2202


<figure>

sterling
ACCURIS
Pathology lab that cares

</figure>


Scan QR code to check
report authenticity

Passport No :


# LABORATORY TEST REPORT


<table>
<tr>
<th>Patient Information</th>
<th colspan="2">Sample Information</th>
<th>Client/Location Information</th>
</tr>
<tr>
<td rowspan="3">Name : Lyubochka Svetka Sex/Age : Male / 41 Y 01-Feb-1982 Ref. Id : Ref. By :</td>
<td>Lab Id Registration on : :</td>
<td>20-Feb-2023 09:10 02232160XXXX</td>
<td>Client Name : Sterling Accuris Buddy Location :</td>
</tr>
<tr>
<td rowspan="2">Collected at : Collected on Sample Type : :</td>
<td>non SAWPL 20-Feb-2023 08:53</td>
<td rowspan="2">Approved on : 20-Feb-2023 14:35 Status : Final Printed On : 28-Feb-2023 10:26 Process At : 1. NRL SAWPL Gujarat Ahmedabad Paldi</td>
</tr>
<tr>
<td>Serum</td>
</tr>
</table>


<table>
<tr>
<th>Test</th>
<th>Result</th>
<th>Unit</th>
<th>Biological Ref. Interval</th>
</tr>
<tr>
<td>HIV Į &amp; Il Ab/Ag with P24 Ag Chemiluminescence</td>
<td>0.070</td>
<td>S/Co</td>
<td>Non Reactive : &lt; 1.0 Reactive : &gt;1.0</td>
</tr>
<tr>
<td>Interpretation</td>
<td>Non Reactive</td>
<td></td>
<td></td>
</tr>
<tr>
<td>HBsAg Chemiluminescence</td>
<td>0.290</td>
<td>S/Co</td>
<td>Non Reactive : &lt; 1.0 Reactive: &gt;1.0</td>
</tr>
<tr>
<td>Interpretation</td>
<td>Non Reactive</td>
<td></td>
<td></td>
</tr>
</table>


Additional Information:

1\. A NON REACTIVE result implies that no Anti HIV-1 or HIV -2 antibodies have been detected in the sample by this method. This means that either
the patient has not been exposed to HIV-1 or HIV-2 infection or the sample has been tested during the "WINDOW PHASE" (before the
development of detectable levels of antibodies).

2\.
A PROVISIONALITY REACTIVE / BORDERLINE REACTIVE result suggests possibility of HIV-1 or/and HIV-2 infection. However these results
must be verified by confirmatory WESTERN BLOT / HIV PCR method before declaring the patient positive for HIV-1 or HIV-2 infection.

3\. Very high levels of IgM Antibodies or Anti-HLA ABC and DR Antibodies can give false positive reaction.

"Pre & Post test counselling for HIV testing is responsibility of reffering Physician.

Dr. Siddharth Thummar
M.D. Pathology

Dr. Sanjeev Shah
MD Path

Dr.Yash Shah
MD Path

This is an Electronically Authenticated Report.

\# Referred Test

<!-- PageNumber="Page 16 of 19" -->
<!-- PageFooter="Sterling Accuris Pathology Laboratory" -->
<!-- PageFooter="National Reference Laboratory: 101 to 109, First Floor, Sankalp Square II, Nr. Old Sharda Mandir Cross Road, B/s. Jalaram Mandir Railway Crossing, Ellisbridge, Ahmedabad, Gujarat- 380006, Ph .: 812 813 0000 Email: customer.care@sterlingaccuris.com | Website: www.sterlingaccuris.com" -->
<!-- PageBreak -->


<figure>
</figure>


MC-2202


<figure>

sterling
ACCURIS
Pathology lab that cares

</figure>


Scan QR code to check
report authenticity

Passport No :


# LABORATORY TEST REPORT


<table>
<tr>
<th>Patient Information</th>
<th colspan="2">Sample Information</th>
<th>Client/Location Information</th>
</tr>
<tr>
<td rowspan="2">Name : Lyubochka Svetka Sex/Age : Male / 41 Y 01-Feb-1982 Ref. Id : Ref. By :</td>
<td>Colle Lab Id : Registration on :</td>
<td>02232160XXXX 20-Feb-2023 09:10</td>
<td>Client Name : Sterling Accuris Buddy Location :</td>
</tr>
<tr>
<td>Collected at : Collected on : Sample Type :</td>
<td>non SAWPL 20-Feb-2023 08:53 EDTA Blood</td>
<td>Approved on : 20-Feb-2023 14:16 Status : Final Printed On : 28-Feb-2023 10:26 Process At : 1. NRL SAWPL Gujarat Ahmedabad Paldi</td>
</tr>
</table>


# HB Electrophoresis By HPLC Instrument Name: BIORAD VARIANT - Il Haemoglobin Testing System


<table>
<tr>
<th>Test</th>
<th>Result</th>
<th>Unit</th>
<th>Biological Ref. Interval</th>
</tr>
<tr>
<td>Hb A</td>
<td>L 84.4</td>
<td>%</td>
<td>96.8 - 97.8</td>
</tr>
<tr>
<td>Hb A2</td>
<td>2.8</td>
<td>%</td>
<td>2.2-3.2</td>
</tr>
<tr>
<td>P2 Peak</td>
<td>5.5</td>
<td>%</td>
<td></td>
</tr>
<tr>
<td>P3 Peak</td>
<td>5.2</td>
<td>%</td>
<td></td>
</tr>
<tr>
<td>Foetal Hb</td>
<td>0.3</td>
<td>%</td>
<td>0.0 - 1.0</td>
</tr>
<tr>
<td>Interpretation</td>
<td colspan="3">Negative for typical beta thalassemia trait.</td>
</tr>
</table>


## Interpretation:

. All results have to be correlated with age and history of blood transfusion if there is history of blood transfusion in last 3 months, repeat testing
after 3 month from last date of transfusion is recommended.

. In case of haemoglobinopathy, parents or family studies and councelling is advised.

. This test detects beta thalassaemia and haemoglobinopathies, DNA analysis is recommended to rule out alpha thalassaemia and silent
carriers.

. Linearity range of HbF is 1-40%, However, values in excess of the reportable range have been provided for ease of interpretation.

· Mild to moderate increase in fetal haemoglobin can be seen in some acquired condition like pregnancy. megaloblastic anaemia, Throtoxicosis,
Hypoxia, Chronic kidney disease, Recovering marrow, MDS, Aplastic anaemia, PNH, Medications (Hydrocyurea, Erythropoietin) ect.

. P3 window-Above 10% is often indicative of either denatured froms of hemoglobins or may suggest a possibility of abnormal haemoglobin
variant. Hence, repeat analysis with fresh sample or DNA studies is advised.

. P2 Window-Above 10% is indicative of either glycated haemoglonin requring correlation with diabetic staus or may suggest a possibility of
abnormal haemoglobin variant further DNA studies for confirmation.

y.

Dr. Hardik Modi
Hematopathologist (G-18097)

Dr. Sanjeev Shah
MD Path

This is an Electronically Authenticated Report.

Dr.Yash Shah
MD Path

\# Referred Test

<!-- PageNumber="Page 17 of 19" -->
<!-- PageFooter="Sterling Accuris Pathology Laboratory National Reference Laboratory: 101 to 109, First Floor, Sankalp Square II, Nr. Old Sharda Mandir Cross Road, B/s. Jalaram Mandir Railway Crossing, Ellisbridge, Ahmedabad, Gujarat- 380006, Ph .: 812 813 0000 Email: customer.care@sterlingaccuris.com | Website: www.sterlingaccuris.com" -->
<!-- PageBreak -->


# Bio-Rad CDM System VII Inst. #1. SN-13939

PATIENT REPORT
V2 BThal

s erling
ACCURIS
Pathology lab that cares

Patient Data

Sample ID:

Patient ID:

Name :

Physician:

Sex :

DOB :

Comments :

022321600126


<table>
<tr>
<td>Analysis Data</td>
<td></td>
</tr>
<tr>
<td>Analysis Performed:</td>
<td>02/20/2023 13:56:59</td>
</tr>
<tr>
<td>Injection Number :</td>
<td>2575</td>
</tr>
<tr>
<td>Run Number :</td>
<td>95</td>
</tr>
<tr>
<td>Rack ID:</td>
<td>0001</td>
</tr>
<tr>
<td>Tube Number :</td>
<td>2</td>
</tr>
<tr>
<td>Report Generated:</td>
<td>02/20/2023 14:04:40</td>
</tr>
<tr>
<td>Operator ID:</td>
<td></td>
</tr>
</table>


<table>
<tr>
<th>Peak Name</th>
<th>Calibrated Area %</th>
<th>Area %</th>
<th>Retention Time (min)</th>
<th>Peak Area</th>
</tr>
<tr>
<td>Unknown</td>
<td>---</td>
<td>0.1</td>
<td>1.00</td>
<td>2400</td>
</tr>
<tr>
<td>F</td>
<td>0.3</td>
<td>---</td>
<td>1.08</td>
<td>8321</td>
</tr>
<tr>
<td>Unknown</td>
<td>---</td>
<td>1.6</td>
<td>1.18</td>
<td>44109</td>
</tr>
<tr>
<td>P2</td>
<td>---</td>
<td>5.5</td>
<td>1.30</td>
<td>148807</td>
</tr>
<tr>
<td>P3</td>
<td>---</td>
<td>5.2</td>
<td>1.72</td>
<td>139183</td>
</tr>
<tr>
<td>Ao</td>
<td>---</td>
<td>84.4</td>
<td>2.34</td>
<td>2277592</td>
</tr>
<tr>
<td>A2</td>
<td>2.8</td>
<td>---</td>
<td>3.64</td>
<td>76999</td>
</tr>
</table>


Total Area:

2,697,411


<table>
<tr>
<td>F Concentration =</td>
<td>0.3 %</td>
</tr>
<tr>
<td>A2 Concentration =</td>
<td>2.8 %</td>
</tr>
</table>


Analysis comments :


<figure>

45.0

37.5

30.0

22.5

op

1.30

15.0

,DB

2200

1.18

1.72

3.64

7.5

2.34

A2-

0.0

IL

0

1

2

3

4

5

6

Time (min.)

</figure>


<!-- PageNumber="Page 18 of 19" -->
<!-- PageBreak -->


<figure>
</figure>


MC-2202


<figure>

sterling
ACCURIS
Pathology lab that cares

</figure>


Scan QR code to check
report authenticity

Passport No :


## LABORATORY TEST REPORT


<table>
<tr>
<th>Patient Information</th>
<th colspan="2">Sample Information</th>
<th>Client/Location Information</th>
</tr>
<tr>
<td rowspan="3">Name : Lyubochka Svetka Sex/Age Male / 41 Y 01-Feb-1982 Ref. Id : Ref. By :</td>
<td>Lab Id Registration on : :</td>
<td>02232160XXXX 20-Feb-2023 09:10</td>
<td>Client Name : Sterling Accuris Buddy Location :</td>
</tr>
<tr>
<td rowspan="2">Collected at : Collected on Sample Type : :</td>
<td>non SAWPL 20-Feb-2023 08:53</td>
<td rowspan="2">Approved on : 20-Feb-2023 11:12 Status : Final Printed On : 28-Feb-2023 10:26 Process At : 1. NRL SAWPL Gujarat Ahmedabad Paldi</td>
</tr>
<tr>
<td>Urine</td>
</tr>
</table>


<table>
<tr>
<th>Test</th>
<th>Result</th>
<th>Unit</th>
<th>Biological Ref. Interval</th>
</tr>
<tr>
<td>Physical &amp; Chemical (Dip strip) examination</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Colour</td>
<td>Pale Yellow</td>
<td></td>
<td>Pale Yellow</td>
</tr>
<tr>
<td>Clearity</td>
<td>Clear</td>
<td></td>
<td>Clear</td>
</tr>
<tr>
<td>PH Double indicafor</td>
<td>6.0</td>
<td></td>
<td>4.6 - 8.0</td>
</tr>
<tr>
<td>Specific Gravity Polyelectrolyte based reaction</td>
<td>1.030</td>
<td></td>
<td>1.005 - 1.030</td>
</tr>
<tr>
<td>Urine Glucose GOD-POD</td>
<td>Present (+)</td>
<td></td>
<td>Absent</td>
</tr>
<tr>
<td>Urine Protein Protein error of indicators</td>
<td>Absent</td>
<td></td>
<td>Absent</td>
</tr>
<tr>
<td>Bilirubin Diazo reaction</td>
<td>Absent</td>
<td></td>
<td>Absent</td>
</tr>
<tr>
<td>Urobilinogen Modified Ehrlich reaction</td>
<td>Absent</td>
<td></td>
<td>Absent</td>
</tr>
<tr>
<td>Urine Ketone Nitroprusside</td>
<td>Absent</td>
<td></td>
<td>Absent</td>
</tr>
<tr>
<td>Nitrite Nitrite reaction</td>
<td>Absent</td>
<td></td>
<td>Absent</td>
</tr>
<tr>
<td>Microscopic Examination</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Pus Cells</td>
<td>1-2</td>
<td></td>
<td>Absent</td>
</tr>
<tr>
<td>Red Cells</td>
<td>Nil</td>
<td>/hpf</td>
<td>0-2</td>
</tr>
<tr>
<td>Epithelial Cells</td>
<td>1-2</td>
<td>/hpf</td>
<td></td>
</tr>
<tr>
<td>Casts</td>
<td>Absent</td>
<td>/hpf</td>
<td>Absent</td>
</tr>
<tr>
<td>Crystals</td>
<td>Absent</td>
<td>/hpf</td>
<td>Absent</td>
</tr>
<tr>
<td>Amorphous Material</td>
<td>Absent</td>
<td></td>
<td></td>
</tr>
</table>


End Of Report

Thote

DR.TEJASWINI DHOTE
M.D. Pathology

Dr. Sanjeev Shah
MD Path

Dr.Yash Shah
MD Path

This is an Electronically Authenticated Report.

\# Referred Test

<!-- PageNumber="Page 19 of 19" -->

Sterling Accuris Pathology Laboratory
National Reference Laboratory: 101 to 109, First Floor, Sankalp Square II, Nr. Old Sharda Mandir Cross Road,
B/s. Jalaram Mandir Railway Crossing, Ellisbridge, Ahmedabad, Gujarat- 380006, Ph .: 812 813 0000
Email: customer.care@sterlingaccuris.com | Website: www.sterlingaccuris.com
